4 ms·
IMO it's not the regulation that is the problem...it's the entire healthcare system we have in the US. Humalog and other types of the same exact insulin are pe
by CarbonCycles 4y ago
IMO it's not the regulation that is the problem...it's the entire healthcare system we have in the US.
Humalog and other types of the same exact insulin are pennies on the dollar in other countries with very different healthcare compensation programs between the vendors and purchases. It's bizarre to say the least.
- anonuser123456 4y agoThis is precisely because the US market pays for all of the risk. Once the risk is paid for by the US market, it’s very cheap to sell extra capacity to other countries. All the fixed costs are already paid for and the risks are low.